We’re on the cusp of a gene editing revolution, are we ready?
By Editorial,
New Scientist
| 07. 27. 2016
THERE’S a certain breed of techno-optimist who likes to talk about “the singularity” – a time when technology progresses so rapidly that life is transformed beyond recognition. The driving force of this hypothetical event is artificial intelligence, but biotech plays a key role too.
...
But there are dangers ahead – not least the science outpacing public consent. Two teams in China have already tried to engineer human embryos. That seems unnecessarily hasty given the ethical issues it raises.
Those who work on CRISPR have a duty to consider not just the science but also how it will be received. As yet, CRISPR has hardly registered in public debate.
Image via Pixabay
Related Articles
By Jennifer Denbow, Guest Contributor
| 10.29.2026
Almost every day I am reminded that we are in the midst of a fertility panic. Whether it’s the Vice President exhorting Americans to have more babies or The New York Times running yet another story about the fertility cliff, fear about falling fertility rates is everywhere. While centrally concerned with declining rates of childbearing, Anna Louie Sussman’s new book, Inconceivable: The Impossibility of Family in an Age of Uncertainty, is a welcome antidote to the panic.
Sussman has written...
By Anna Louie Sussman, The New Republic | 10.26.2026
There’s a certain kind of novel that’s not quite apocalyptic enough to be science fiction, but just far-fetched enough to be speculative. No one is from outer space; society has not yet been carved up into a hierarchy of groups...
By Ariana Aspuru and Noel King, Vox | 10.14.2026
For some couples, surrogacy is a miracle: an opportunity to have a child even if they’re unable to conceive one naturally. But it’s also big business. Not only is surrogacy expensive — think six figures — but it’s also largely...
By Sonia Suter and Naomi Cahn, The Conversation | 10.09.2026